![]() |
市場調查報告書
商品編碼
1775455
醫療輻射屏蔽市場:2025-2030 年預測Medical Radiation Shielding Market - Forecasts from 2025 to 2030 |
醫療輻射屏蔽市場預計將從 2025 年的 13.4 億美元成長到 2030 年的 17.21 億美元,複合年成長率為 5.14%。
慢性病盛行率上升
慢性疾病(尤其是癌症)的日益普及是醫療輻射屏蔽市場的主要驅動力。根據美國衛生研究院的數據,預計到2024年,光在美國就將診斷出2,001,140例新發癌症病例,導致611,720人死亡。在全球範圍內,癌症仍然是主要的死亡原因,因此需要先進的診斷成像和放射治療。 X光、 電腦斷層掃描和放射治療等程序需要強大的屏蔽來保護患者和醫護人員免受有害電離輻射的傷害,這推動了對屏蔽材料和解決方案的需求。
診斷影像和放射治療的成長
診斷影像中心和放射治療設施的擴張正在推動市場成長。根據美國核子醫學會 (美國 Society of Nuclear Medicine) 的報告,對早期疾病檢測和預防保健的重視,導致美國每年進行包括核子醫學在內的診斷影像程序的數量增加到近 2,000 萬次。 X 光、CT、MRI 和放射治療等診斷和治療應用的激增需要先進的屏蔽解決方案,以確保醫院、診斷中心以及牙科和獸醫診所等專科機構的安全。
醫護人員的健康風險
慢性低劑量輻射暴露對醫護人員的健康構成重大風險,包括增加腦腫瘤、皮膚癌、甲狀腺癌、乳癌、黑色素瘤、白內障、中風、動脈硬化症和認知障礙的發生率。傳統的鉛罩衣雖然有效,但體積龐大,會給醫生帶來身體壓力,尤其是下背部疼痛。頭部和眼睛等未受防護的部位會增加腦腫瘤和白內障的風險。這些擔憂促使人們尋求輕便、有效的防護解決方案,以提高職業安全。
技術創新
市場參與者正在透過創新的屏蔽解決方案來應對安全挑戰。 2023 年,SDS Specialist Door Solutions 推出了專為醫療機構設計的 Shieldoor 鉛襯 X 光門,為放射治療機構提供可客製化的輻射防護。 2023 年 4 月,Million Technologies 收購了 PTW Dosimetry,增強了其輻射屏蔽和監測系統產品組合。 Radiaction Medical Ltd. 的 Shield System 於 2023 年 4 月獲得 FDA 510(k) 許可,並獲得 1000 萬美元用於在美國推出這種創新的輻射防護解決方案並在歐洲擴展。在印度,先進材料和製程研究所 (CSIR-AMPRI) 開發了無鉛輻射屏蔽瓦,並獲得了原子能美國核能管理委員會的批准。到 2024 年,馬哈拉斯特拉邦Saideep 醫院的 X 光室、 電腦斷層掃描室和心導管室將安裝 2600 塊屏蔽瓦。此外,MXR Imaging 於 2023 年 8 月收購了 Spartan Shield,增強了其 MRI 套件的射頻、磁場和輻射防護能力。這些進步,包括鎢和鉍合金等無鉛材料的採用,反映了公司向更安全、更輕、更環保的屏蔽解決方案的轉變。
The Medical Radiation Shielding Market is expected to grow from USD 1.340 billion in 2025 to USD 1.721 billion in 2030, at a CAGR of 5.14%.
Rising Prevalence of Chronic Diseases
The increasing incidence of chronic diseases, particularly cancer, is a primary driver of the medical radiation shielding market. In 2024, an estimated 2,001,140 new cancer cases were diagnosed in the United States alone, with 611,720 deaths, according to the National Institutes of Health. Globally, cancer remains a leading cause of mortality, necessitating advanced diagnostic imaging and radiation therapy. Procedures such as X-rays, CT scans, and radiation therapy require robust shielding to protect patients and healthcare workers from harmful ionizing radiation, driving demand for shielding materials and solutions.
Growing Diagnostic Imaging and Radiation Therapy
The expansion of diagnostic imaging centers and radiation therapy facilities is fueling market growth. The emphasis on early disease detection and preventive healthcare has increased the number of imaging procedures, including nearly 20 million nuclear medicine procedures performed annually in the U.S., as reported by the Society of Nuclear Medicine. This surge in diagnostic and therapeutic applications, including X-ray, CT, MRI, and radiation therapy, necessitates advanced shielding solutions to ensure safety in hospitals, diagnostic centers, and specialized facilities like dental and veterinary clinics.
Health Risks to Medical Professionals
Chronic low-dose radiation exposure poses significant health risks to medical staff, including increased incidences of brain, skin, thyroid, and breast cancers, melanomas, cataracts, strokes, atherosclerotic disease, and cognitive impairments. Traditional lead gowns, while effective, are bulky and cause physical strain, particularly back pain, among physicians. Unshielded areas, such as the head and eyes, heighten risks of brain tumors and cataracts. These concerns are driving innovation in lightweight, effective shielding solutions to enhance occupational safety.
Technological Innovations
Market players are addressing safety challenges through innovative shielding solutions. In 2023, SDS Specialist Door Solutions launched Shieldoor lead-lined X-ray doors, designed for healthcare settings to provide customizable radiation protection in radiology facilities. In April 2023, Mirion Technologies acquired PTW Dosimetry, enhancing its portfolio of radiation shielding and monitoring systems. Radiaction Medical Ltd. received FDA 510(k) clearance in April 2023 for its Shield System, securing USD 10 million to launch this innovative radiation protection solution in the U.S. and expand in Europe. In India, the Advanced Materials and Processes Research Institute (CSIR-AMPRI) developed lead-free radiation shielding tiles, approved by the Atomic Energy Regulatory Board, with 2,600 tiles installed at Saideep Hospital in Maharashtra for X-ray rooms, CT scan rooms, and cath labs by 2024. Additionally, in August 2023, MXR Imaging Inc. acquired Spartan Shielding, bolstering its capabilities in RF, magnetic, and radiation protection for MRI rooms. These advancements, including lead-free materials like tungsten and bismuth alloys, reflect a shift toward safer, lighter, and environmentally friendly shielding solutions.
Market Segmentation
The market is segmented by product type, solution, and end-user. In 2023, the shields segment held a 41.7% market share due to its customizable protection for radiation therapy, as reported by Coherent Market Insights. X-ray shielding dominated in 2023, accounting for 45% of revenue, driven by widespread use in medical imaging, while MRI shielding is the fastest-growing segment due to increasing demand for advanced MRI technologies. Diagnostic shielding led the solution segment in 2023, but radiation therapy shielding is expected to grow rapidly, fueled by rising cancer treatments. Hospitals and diagnostic centers held the largest end-user share in 2023, with research institutes poised for significant growth.
Regional Insights
North America accounted for 37.09% of the market in 2023, driven by advanced healthcare infrastructure, high cancer prevalence, and stringent safety regulations. The U.S. performed over 80 million CT scans in 2023, necessitating robust shielding solutions. Asia-Pacific is the fastest-growing region, propelled by healthcare infrastructure investments in countries like China and India, where cancer incidence is projected to rise by 12.8% by 2025, according to the NIH.
Market Challenges
High costs of advanced shielding materials and R&D, coupled with a shortage of skilled radiologists and oncologists, pose challenges. Regulatory compliance and the environmental concerns of lead-based shielding also necessitate ongoing innovation in non-toxic alternatives.
Conclusion
The medical radiation shielding market is set to grow from USD 1.51 billion in 2024 to USD 2.5 billion by 2032, at a CAGR of 6.52%, driven by rising chronic disease prevalence, diagnostic imaging growth, and occupational safety concerns. Innovations in lead-free and lightweight shielding solutions, alongside regional healthcare investments, are key growth catalysts. However, high costs and regulatory challenges require strategic advancements to sustain market momentum.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
Segmentation